Whitener Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Whitener Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,000	Closed	-$237K	–	133
2020 Q3	$237K	Hold	5,000	–	–	0.11%	113
2020 Q2	$294K	Hold	5,000	–	–	0.15%	101
2020 Q1	$236K	Hold	5,000	–	–	0.15%	104
2019 Q4	$302K	Hold	5,000	–	–	0.16%	106
2019 Q3	$299K	Hold	5,000	–	–	0.16%	103
2019 Q2	$321K	Hold	5,000	–	–	0.18%	103
2019 Q1	$405K	Sell	5,000 -1,590	-24%	-$103K	0.26%	85
2018 Q4	$356K	Hold	6,590	–	–	0.26%	89
2018 Q3	$339K	Buy	+6,590	New	+$310K	0.22%	97
2018 Q2	–	Sell	-2,090	Closed	-$92K	–	248
2018 Q1	$92K	Sell	2,090 -210	-9%	-$10.7K	0.07%	150
2017 Q4	$115K	Buy	+2,300	New	+$126K	0.1%	138

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Whitener Capital Management's IONS Position: Q4 2020 in Review

Whitener Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2020, closing a stake of 5,000 shares — an estimated $237K sold.

Whitener Capital Management first reported a position in IONS in Q4 2017 and held it in 11 quarters. The position peaked at $405K in Q1 2019. 382 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

Whitener Capital Management reported no remaining Ionis Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Whitener Capital Management sold 5,000 Ionis Pharmaceuticals shares in Q4 2020, an estimated $237K.
Whitener Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2017 and held it in 11 quarters.
Whitener Capital Management's Ionis Pharmaceuticals position peaked at $405K in Q1 2019.
382 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on Whitener Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.